Anti-TRIM21+ ILD patients showed a significant increase of DLCO at 1 and 5 years of follow-up.Anti-TRIM21 antibody and dyspnea at onset in IIM could predicted the development of ILD. Here, TRIM21 is linked to interstitial lung disease.